MedPath

Effect of Nigella sativa oil in patients with polycystic ovary syndrome

Phase 3
Recruiting
Conditions
Polycystic ovary syndrome.
Polycystic ovarian syndrome
E28.2
Registration Number
IRCT20230125057222N1
Lead Sponsor
Ardabil University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
60
Inclusion Criteria

Oligomenorrhea or lack of ovulation
Polycystic ovaries based on ultrasound
Androgenic hormone changes in laboratory or clinical form (the presence of hirsutism)

Exclusion Criteria

Type 2 diabetes -
thyroid disease -
adrenal hyperplasia
autoimmune diseases -
- hyperprolactinemia
People with structured physical activity or scheduled exercise
If three months before entering the study, they use a special diet or special drugs that may affect the results, they will be excluded from the study, such as anti-obesity drugs, ovulation stimulants, antidepressants, insulin sensitivity, oral contraceptives, aspirin, and Anti-prostaglandin drugs
If there are signs of pregnancy, they will be excluded from the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Interleukin 6,. Timepoint: Before and after 12 weeks of intervention. Method of measurement: Determination of serum level.;TNF-alpha. Timepoint: Before and after 12 weeks of intervention. Method of measurement: Determination of serum level.;Lipid profile. Timepoint: Before and after 12 weeks of intervention. Method of measurement: Determination of serum level.;Insulin. Timepoint: Before and after 12 weeks of intervention. Method of measurement: Determination of serum level.;Fasting blood sugar. Timepoint: Before and after 12 weeks of intervention. Method of measurement: Determination of serum level.
Secondary Outcome Measures
NameTimeMethod
Insulin resistance index (QUICKI), insulin sensitivity index (HOMA-IR). Timepoint: Before and 12 weeks after the intervention. Method of measurement: Calculation of indices.
© Copyright 2025. All Rights Reserved by MedPath